Milestone Pharmaceuticals Inc. (MIST): Net Income
-$63.06M
Year ended 2025-12-31
-$84.01M
Trailing 12 months to 2026-06-30
| Period ended | Net Income | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | -$63.06M | n/m | 2026-03-20, From 2025-01-01 |
| 2024-12-31 | -$41.52M | n/m | 2026-03-20, From 2024-01-01 |
| 2023-12-31 | -$59.69M | n/m | 2025-03-13, From 2023-01-01 |
| 2022-12-31 | -$58.39M | n/m | 2024-03-21, From 2022-01-01 |
| 2021-12-31 | -$42.85M | n/m | 2023-03-29, From 2021-01-01 |
| 2020-12-31 | -$49.97M | n/m | 2022-03-24, From 2020-01-01 |
| 2019-12-31 | -$55.23M | n/m | 2021-03-29, From 2019-01-01 |
| 2018-12-31 | -$23.18M | n/a | 2020-10-23, From 2018-01-01 |
Net Income at similar companies
| Company | Year ended | Net Income | Change YoY |
|---|---|---|---|
| Milestone Pharmaceuticals Inc. (MIST) | 2025-12-31 | -$63.06M | n/m |
| Korro Bio, Inc. (KRRO) | 2025-12-31 | -$117.26M | n/m |
| Rafael Holdings, Inc. (RFL) | 2025-07-31 | -$30.52M | n/m |
| Rezolute, Inc. (RZLT) | 2026-06-30 | -$77.59M | n/m |
| Avalo Therapeutics, Inc. (AVTX) | 2025-12-31 | -$78.26M | n/m |
| Sagimet Biosciences Inc. (SGMT) | 2025-12-31 | -$51.04M | n/m |
| PMV Pharmaceuticals, Inc. (PMVP) | 2025-12-31 | -$77.74M | n/m |
| Aardvark Therapeutics, Inc. (AARD) | 2025-12-31 | -$57.59M | n/m |
| Camp4 Therapeutics Corp (CAMP) | 2025-12-31 | -$80.40M | n/m |
Compare MIST, KRRO, RFL, RZLT side by side · Screen every company in Pharmaceutical Preparations ↗